These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8909427)

  • 1. Neuropsychiatric aspects of progressive supranuclear palsy.
    Litvan I; Mega MS; Cummings JL; Fairbanks L
    Neurology; 1996 Nov; 47(5):1184-9. PubMed ID: 8909427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric features of corticobasal degeneration.
    Litvan I; Cummings JL; Mega M
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):717-21. PubMed ID: 9810944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders.
    Kulisevsky J; Litvan I; Berthier ML; Pascual-Sedano B; Paulsen JS; Cummings JL
    Mov Disord; 2001 Nov; 16(6):1098-104. PubMed ID: 11748741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral abnormalities in progressive supranuclear palsy.
    Gerstenecker A; Duff K; Mast B; Litvan I;
    Psychiatry Res; 2013 Dec; 210(3):1205-10. PubMed ID: 24035530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Neuropsychiatric Inventory to Characterize the Course of Neuropsychiatric Symptoms in Progressive Supranuclear Palsy.
    Ječmenica-Lukić M; Pekmezović T; Petrović IN; Tomić A; Svetel M; Kostić VS
    J Neuropsychiatry Clin Neurosci; 2018; 30(1):38-44. PubMed ID: 28506191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy.
    Ou R; Liu H; Hou Y; Wei Q; Cao B; Zhao B; Shang H
    J Neurol Sci; 2017 Sep; 380():182-186. PubMed ID: 28870563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotypic behaviours in frontotemporal dementia and progressive supranuclear palsy.
    Prioni S; Redaelli V; Soliveri P; Fetoni V; Barocco F; Caffarra P; Scaglioni A; Tramacere I; Girotti F
    Cortex; 2018 Dec; 109():272-278. PubMed ID: 30399478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of decline in progressive supranuclear palsy.
    Litvan I; Kong M
    Mov Disord; 2014 Apr; 29(4):463-8. PubMed ID: 24615741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic.
    Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Matsuzaki S; Tuyuguchi A; Kashiwagi H; Ikeda M
    Psychogeriatrics; 2011 Mar; 11(1):54-9. PubMed ID: 21447110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.
    Aarsland D; Litvan I; Larsen JP
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):42-9. PubMed ID: 11207328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy.
    Borroni B; Alberici A; Agosti C; Cosseddu M; Padovani A
    Int Psychogeriatr; 2009 Jun; 21(3):463-8. PubMed ID: 19323870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, cognitive, and behavioural correlates of white matter damage in progressive supranuclear palsy.
    Agosta F; Galantucci S; Svetel M; Lukić MJ; Copetti M; Davidovic K; Tomić A; Spinelli EG; Kostić VS; Filippi M
    J Neurol; 2014 May; 261(5):913-24. PubMed ID: 24599641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.
    Shimabukuro J; Awata S; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):274-9. PubMed ID: 15896220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric symptoms in progressive supranuclear palsy.
    Menza MA; Cocchiola J; Golbe LI
    Psychosomatics; 1995; 36(6):550-4. PubMed ID: 7501785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of behavioral changes in Alzheimer's disease.
    Mega MS; Cummings JL; Fiorello T; Gornbein J
    Neurology; 1996 Jan; 46(1):130-5. PubMed ID: 8559361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of atypical progressive supranuclear palsy.
    Spaccavento S; Del Prete M; Craca A; Loverre A
    Clin Interv Aging; 2014; 9():31-9. PubMed ID: 24368882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.